Daily Archives: March 31, 2017
Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
It is with great interest that we read the publication written by Salem et al1: “Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.” This article gave results… Continue reading
Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
We read with great interest the paper “Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.”1 We commend the authors for studying this very important subject in … Continue reading
Covering the Cover
In a study of 138 treatment-naïve pediatric inflammatory bowel disease patients and 49 controls, rectal expression of type 2 and type 17 immune response genes discriminated ulcerative colitis from Crohn’s colitis and was associated with clinical out… Continue reading